All filters
Abstracts
HIV infection does not increase the frequency of phosphorylated tau and beta amyloid in brain in late middle age
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Cellular and molecular assessment of muscle function as a predictor of ageing phenotype in older PLWH
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Frailty phenotype in older virologically suppressed PLWHIV is strongly correlated with specific comorbidities and tobacco use
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
The aging of HIV epidemic in Ukraine: new HIV diagnoses from 2015-2018 and related mortality among adults ≥50 years
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
The association between mitochondrial DNA copy number and longitudinal lung function decline among people with or at risk of HIV
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Elevated cardiac risk score by ASCVD calculation is associated with albuminuria in older people living with HIV
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Lipidome abnormalities and altered macrophage phenotype may contribute to cardiovascular disease risk in the aging HIV population
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Epigenetic age acceleration and non-AIDS defining cancers among HIV infected adults
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Impact of testosterone use on grip strength in men aging with HIV
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Food insecurity and frailty among women in the US
Presented at:
International Workshop on HIV & Aging 2019
Abstracts
Blunted increase in muscle mass after exercise training in people aging with HIV
Presented at:
International Workshop on HIV & Aging 2019
Videos
Abstract # 1 - Characteristics of women diagnosed with HIV in the WHO European Region and predictors of late diagnosis - Otilia MĂĄrdh, ECDC, Sweden
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Videos
ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette Haberl
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
An assessment of the effects of dolutegravir on gene expression and levonorgestrel clearance in human hepatocytes in vitro
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Cobicistat (COBI)-boosted Protease Inhibitors (PIs) plasma and intracellular (IC) pharmacokinetics (PK) in nicotine users
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Glecaprevir/pibrentasvir pharmacokinetics in HCV/HIV patients co-administered with antiretroviral drugs
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
The valproic acid – dolutegravir drug-drug interaction is based on displacement of protein binding and unlikely to be clinically relevant
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Valproic acid co-administration is not associated with lower non-dolutegravir antiretrovirals’ exposures
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Short-term intravenous proton pump inhibitors and histamine H2 antagonists do not negatively affect sustained virologic response in hepatitis C cirrhotic patients treated with ledipasvir or velpatasvir containing antiviral regimens: a case series
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
High incidence of drug-drug interactions with hepatitis C direct-acting antivirals in patients hospitalized during their treatment
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Effect of tenofovir and bacavir on dolutegravir transport in vitro and in vivo
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Review on drug interactions of ART and tuberculosis medications
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Comparison of relative bioavailability of pediatric triumeq and pediatric dolutegravir/lamivudine dispersible tablets to conventional film coated tablets in healthy adults
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Influence of SLCO1B1 polymorphisms on lopinavir plasma concentration in Serbian HIV/AIDS patients
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019